ABSTRACT

The costs associated with a drug's clinical trials are so significant that it has become necessary to validate both its safety and efficacy in animal models prior to the continued study of the drug in humans.

Featuring contributions from distinguished researchers in the field of cognitive therapy research, Animal Models of Cognitive Impairmen

chapter 1|4 pages

Introduction

chapter 2|16 pages

Muscarinic Receptor Antagonists in Rats

chapter 3|16 pages

Nicotinic Receptor Antagonists in Rats

chapter 11|24 pages

Cholinergic Receptor Knockout Mice

chapter 13|16 pages

Cognitive Pharmacology in Aging Macaques

chapter 16|14 pages

Cognition Models and Drug Discovery